| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2022 | XAIR Beyond Air, Inc. | Bentsur Ron64 | Director | Sell | 40,000 | $6.53 | $261,104.00 | -21.9% | +18.5% | -36.3% | |
| Jun 30, 2022 | NVNO Envveno Medical Corp | Shrivastava Sanjay | Director | Buy | 1,000 | $3.85 | $3,850.00 | +34.6% | +64.0% | -18.5% | |
| Jun 30, 2022 | EKSO Ekso Bionics Holdings, Inc. | Davis Scott G.61 | President &COO | Sell | 4,997 | $1.72 | $8,594.84 | -1.3% | -7.3% | -13.3% | |
| Jun 30, 2022 | XAIR Beyond Air, Inc. | Lisi Steven A.50 | CEO And Chairman Of The Board | Buy | 73,000 | $6.63 | $483,698.00 | +5.3% | +18.5% | -36.3% | |
| Jun 30, 2022 | XAIR Beyond Air, Inc. | Avniel Amir63 | COO And President | Sell | 68,100 | $6.51 | $443,073.21 | -13.9% | +18.5% | -36.3% | |
| Jun 30, 2022 | TELA Tela Bio, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 3,567 | $7.00 | $24,968.98 | +0.1% | +21.0% | +44.5% | |
| Jun 30, 2022 | MASS 908 Devices Inc. | Brown Christopher D.85 | Chief Technology Officer | Sell | 20,171 | $20.20 | $407,487.62 | -1.1% | -19.7% | -66.7% | |
| Jun 29, 2022 | MASS 908 Devices Inc. | Turner Michael S.75 | VP, General Counsel | Sell | 5,000 | $20.03 | $100,150.00 | -100% | -25.5% | -66.8% | |
| Jun 29, 2022 | LFWD Lifeward Ltd. | Lind Global Fund II LP47 | - | Buy | 36,315 | $0.94 | $34,262.40 | +0.2% | -7.6% | -38.0% | |
| Jun 29, 2022 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 3,725 | $1.84 | $6,870.25 | -3.1% | -6.6% | +95.0% | |
| Jun 29, 2022 | SMTI Sanara Medtech Inc. | Fleming Zachary B.50 | Chief Executive Officer | Sell | 363 | $21.00 | $7,623.00 | -0.5% | +32.0% | +102.3% | |
| Jun 28, 2022 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality Officer | Sell | 598 | $14.86 | $8,886.28 | -0.5% | +47.3% | +54.1% | |
| Jun 28, 2022 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 495 | $14.86 | $7,355.70 | -0.5% | +47.3% | +54.1% | |
| Jun 28, 2022 | BLFS Biolife Solutions Inc | Rice Michael72 | CEO | Sell | 889 | $14.86 | $13,210.54 | -0.2% | +47.3% | +54.1% | |
| Jun 28, 2022 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 704 | $14.86 | $10,461.44 | -0.3% | +47.3% | +54.1% | |
| Jun 28, 2022 | TMDX Transmedics Group, Inc. | Carey John F | VP Of Operations | Sell | 2,724 | $32.87 | $89,537.88 | -87.8% | +27.3% | +174.4% | |
| Jun 28, 2022 | TELA Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P.57 | See Footnote 2 | Buy | 15,000 | $7.14 | $107,050.00 | +0.1% | +16.2% | +39.1% | |
| Jun 28, 2022 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | President And CEO | Sell | 19,907 | $3.34 | $66,537.11 | -0.8% | +12.3% | -40.6% | |
| Jun 27, 2022 | RBOT Vicarious Surgical Inc. | Morris June89 | CLO, GC And Secretary | Sell | 2,266 | $3.61 | $8,180.26 | -0.7% | +3.0% | -46.4% | |
| Jun 27, 2022 | NVNO Envveno Medical Corp | Berman Robert Andrew | Chief Executive Officer | Buy | 2,500 | $3.80 | $9,500.00 | +1.2% | +52.5% | -24.1% | |
| Jun 27, 2022 | MASS 908 Devices Inc. | Griffith Joseph H. IV81 | Chief Financial Officer | Sell | 18,188 | $19.12 | $347,683.49 | -9.0% | -20.8% | -65.3% | |
| Jun 27, 2022 | TMDX Transmedics Group, Inc. | Carey John F | VP Of Operations | Sell | 6,276 | $32.58 | $204,475.72 | -89.2% | +23.9% | +153.8% | |
| Jun 24, 2022 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 456 | $15.95 | $7,273.20 | -1.0% | +41.9% | +46.4% | |
| Jun 24, 2022 | NXGL Nexgel, Inc. | Stefansky David54 | Director | Buy | 3,128 | $1.60 | $4,992.91 | +34.4% | +2.8% | +66.3% | |
| Jun 24, 2022 | SMTI Sanara Medtech Inc. | Fleming Zachary B.50 | Chief Executive Officer | Sell | 457 | $21.00 | $9,597.00 | -1.1% | +40.1% | +92.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.